Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ALXN Insider Trading

ALXN | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ALXN provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2013-09-07 00:11 2013-09-04 BELL LEONARD Director, Officer - CEO SELL $110.07 1,850 $203,630 1,001,669 -0.2%
2013-09-04 01:11 2013-08-30 Carmichael Clare Officer - SVP, Chief HR Officer SELL $107.58 1,237 $133,075 9,463 -11.6%
2013-09-04 01:11 2013-08-29 BELL LEONARD Director, Officer - CEO SELL $110.19 33,150 $3,652,832 1,003,519 -3.2%
2013-08-17 00:54 2013-08-15 BELL LEONARD Director, Officer - CEO SELL $106.08 140,000 $14,851,774 1,036,669 -11.9%
2013-08-08 00:26 2013-08-05 Hallal David Officer - EVP, Chief Commercial Officer SELL $116.87 730 $85,315 88,178 -0.8%
2013-08-08 00:26 2013-08-05 Sinha Vikas Officer - EVP & CFO SELL $116.87 852 $99,573 310,808 -0.3%
2013-08-08 00:27 2013-08-05 SQUINTO STEPHEN P Officer - EVP, Chief Global Ops. Officer SELL $116.87 852 $99,573 106,490 -0.8%
2013-08-08 00:27 2013-08-05 BELL LEONARD Director, Officer - CEO SELL $116.87 2,919 $341,144 1,176,669 -0.2%
2013-08-03 00:02 2013-08-02 SQUINTO STEPHEN P Officer - EVP, Chief Global Ops. Officer OPT+S $115.33 14,125 $1,629,018 107,342 0.0%
2013-08-02 00:04 2013-07-30 Hallal David Officer - EVP, Chief Commercial Officer SELL $110.86 746 $82,702 88,908 -0.8%
2013-08-02 00:04 2013-07-30 Sinha Vikas Officer - EVP & CFO SELL $110.86 995 $110,306 311,660 -0.3%
2013-08-02 00:04 2013-07-30 SQUINTO STEPHEN P Officer - EVP, Chief Global Ops. Officer SELL $110.86 1,120 $124,163 107,342 -1.0%
2013-08-02 00:04 2013-07-30 BELL LEONARD Director, Officer - CEO SELL $114.62 212,737 $24,384,043 1,179,588 -15.3%
2013-07-16 23:44 2013-07-12 Hallal David Officer - EVP, Chief Commercial Officer OPT+S $120.00 50,000 $6,000,000 89,654 0.0%
2013-07-16 23:48 2013-07-12 Sinha Vikas Officer - EVP & CFO OPT+S $120.00 50,000 $6,000,000 312,655 0.0%
2013-07-16 23:47 2013-07-12 SQUINTO STEPHEN P Officer - EVP, Chief Global Ops. Officer OPT+S $119.90 18,000 $2,158,200 108,462 0.0%
2013-07-03 23:49 2013-07-01 SQUINTO STEPHEN P Officer - EVP, Global Ops. Officer OPT+S $94.97 44,125 $4,190,622 108,462 0.0%
2013-05-24 00:03 2013-05-22 NORBY R DOUGLAS Director OPT+S $102.77 40,000 $4,110,712 56,144 0.0%
2013-05-23 02:00 2013-05-20 KELLER WILLIAM R Director OPT+S $103.00 9,770 $1,006,310 12,276 0.0%
2013-05-16 00:23 2013-05-14 BELL LEONARD Director, Officer - CEO SELL $105.74 31,113 $3,289,758 1,361,212 -2.2%
2013-05-15 00:08 2013-05-10 BELL LEONARD Director, Officer - CEO SELL $100.85 41,220 $4,156,926 1,392,325 -2.9%
2013-05-02 01:29 2013-04-29 Veneman Ann M Director SELL $99.00 3,115 $308,385 5,918 -34.5%
2013-05-02 01:29 2013-04-29 MATHIS LARRY Director SELL $99.03 3,115 $308,478 29,456 -9.6%
2013-05-02 01:29 2013-04-29 SQUINTO STEPHEN P Officer - EVP, Global Ops. Officer OPT+S $98.96 36,499 $3,612,051 108,462 0.0%
2013-04-19 23:25 2013-04-17 BELL LEONARD Director, Officer - CEO SELL $95.04 35,000 $3,326,400 1,433,545 -2.4%
2013-04-12 23:09 2013-04-10 BELL LEONARD Director, Officer - CEO SELL $100.24 26,700 $2,676,408 1,468,545 -1.8%
2013-04-03 23:45 2013-04-01 BELL LEONARD Director, Officer - CEO SELL $95.95 43,300 $4,154,752 1,495,245 -2.8%
2013-03-12 23:39 2013-03-08 SQUINTO STEPHEN P Officer - EVP, Head of R&D OPT+S $91.36 20,000 $1,827,162 108,462 0.0%
2013-03-12 23:39 2013-03-08 PARVEN ALVIN S Director SELL $92.00 3,115 $286,580 7,311 -29.9%
2013-02-07 02:07 2013-02-04 Hallal David Officer - EVP, Chief Commercial Officer SELL $96.18 2,085 $200,537 69,246 -2.9%
2013-02-07 02:08 2013-02-04 Sinha Vikas Officer - EVP & CFO SELL $95.81 3,483 $333,692 308,155 -1.1%
2013-02-07 02:07 2013-02-04 SQUINTO STEPHEN P Officer - EVP, Head of R&D SELL $95.68 2,572 $246,081 81,925 -3.0%
2013-02-07 02:08 2013-02-04 BELL LEONARD Director, Officer - CEO SELL $96.27 11,880 $1,143,717 1,522,045 -0.8%
2013-01-31 01:07 2013-01-28 Hallal David Officer - EVP. Global Commercial Ops SELL $94.42 1,144 $108,016 71,331 -1.6%
2013-01-31 01:12 2013-01-28 Sinha Vikas Officer - EVP & CFO SELL $94.41 1,982 $187,124 311,638 -0.6%
2013-01-31 01:23 2013-01-28 SQUINTO STEPHEN P Officer - EVP, Head of R&D SELL $94.41 1,482 $139,911 84,497 -1.7%
2013-01-31 01:21 2013-01-28 BELL LEONARD Director, Officer - CEO SELL $94.41 5,242 $494,886 1,533,925 -0.3%
2013-01-18 01:02 2013-01-15 BELL LEONARD Director, Officer - CEO SELL $98.58 35,000 $3,450,405 1,539,167 -2.2%
2013-01-12 00:31 2013-01-09 BELL LEONARD Director, Officer - CEO SELL $99.96 27,197 $2,718,612 1,574,167 -1.7%
2013-01-05 00:25 2013-01-02 BELL LEONARD Director, Officer - CEO SELL $99.93 7,803 $779,754 1,601,364 -0.5%
2012-12-21 00:59 2012-12-18 BELL LEONARD Director, Officer - CEO SELL $95.68 35,000 $3,348,800 1,609,167 -2.1%
2012-12-15 00:53 2012-12-12 Veneman Ann M Director SELL $95.00 4,579 $435,005 6,562 -41.1%
2012-12-13 02:19 2012-12-10 NORBY R DOUGLAS Director OPT+S $93.00 22,000 $2,046,000 38,673 0.0%
2012-12-01 00:38 2012-11-28 BELL LEONARD Director, Officer - CEO OPT+S $94.97 48,515 $4,607,334 1,644,167 0.0%
2012-11-21 22:48 2012-11-19 PARVEN ALVIN S Director OPT+S $91.30 30,000 $2,739,054 7,311 0.0%
2012-11-02 23:30 2012-10-31 Coissac Patrice Officer - SVP & Pres. ALXN Pharma Int'l SELL $91.16 84,764 $7,726,891 1,118 -98.7%
2012-11-02 23:09 2012-10-31 BELL LEONARD Director, Officer - CEO OPT+S $94.99 7,982 $758,237 1,679,167 0.0%
2012-10-03 23:28 2012-10-01 BELL LEONARD Director, Officer - CEO OPT+S $115.27 18,070 $2,082,947 1,681,834 0.0%
2012-09-29 00:43 2012-09-27 BELL LEONARD Director, Officer - CEO OPT+S $111.97 143,100 $16,022,592 1,672,114 0.0%
2012-08-29 23:42 2012-08-27 Coissac Patrice Officer - SVP & Pres. ALXN Pharma Int'l OPT+S $106.82 63,483 $6,781,203 85,882 0.0%
SHOW ENTRIES

How to Interpret $ALXN Trades

Not every insider transaction in ALXN is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ALXN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ALXN

Insider activity data for ALXN is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ALXN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.